It has been reported that knock-down of either PKM isoforms in lung carcinoma cell lines H1299 and A549 resulted in different phenotypes, due to deficiency in AMP-activated protein kinase signaling in A549 cells [104]. This evidence concerns the gene PKM and lung carcinoma.